The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Research Report: Human CALCOCO1 (UniProt Q9P1Z2) — Functional Annotation

0. Target verification (critical identity check)

The protein described in UniProt as Calcium-binding and coiled-coil domain-containing protein 1 with accession Q9P1Z2 corresponds to the human gene CALCOCO1 and is widely referenced in the literature under the alternative name CoCoA (coiled-coil coactivator), as well as in autophagy literature as CALCOCO1. The sources used here explicitly use these names for the same protein and experimentally interrogate CALCOCO1/CoCoA in human cell systems, matching the requested target context. (stefely2020massspectrometryproteomics pages 8-11, kim2008ccar1akey pages 1-2)

1. Key concepts and definitions (current understanding)

1.1 CALCOCO1 as a selective-autophagy receptor/adaptor

In current autophagy nomenclature, CALCOCO1 is best supported as a soluble selective-autophagy receptor/adaptor that links specific organelle membranes (especially ER subdomains) to the autophagosome machinery via ATG8-family proteins (LC3/GABARAP family). (stefely2020massspectrometryproteomics pages 14-17, stefely2020massspectrometryproteomics pages 11-14)

Operational definition used in key primary studies: CALCOCO1 is considered an ER-selective autophagy (reticulophagy) receptor because genetic deletion reduces ER-phagy reporter flux and because CALCOCO1 physically interacts with LC3-family proteins through short linear motifs (LIR/CLIR). (stefely2020massspectrometryproteomics pages 14-17, stefely2020massspectrometryproteomics pages 11-14)

1.2 ATG8-family binding motifs: LIR and CLIR

A central mechanistic concept for CALCOCO1 function is binding to ATG8-family proteins. Stefely et al. experimentally dissected two classes of motifs:
- A canonical LIR motif (LC3-interacting region), where the W47A mutation abolished detectable binding to MAP1LC3C, MAP1LC3B, and GABARAPL2 in co-immunoprecipitation experiments. (stefely2020massspectrometryproteomics pages 11-14)
- A non-canonical CLIR (MAP1LC3C-interacting region), where L140A/V142A weakened MAP1LC3C binding, consistent with partial contribution to LC3C preference. (stefely2020massspectrometryproteomics pages 11-14)

1.3 CALCOCO1 as a transcriptional coregulator (“CoCoA”)

Independently of autophagy, CALCOCO1 was originally characterized as CoCoA, a transcriptional coactivator/coregulator that integrates signals from transcription factors (including nuclear receptors and GATA1) with the Mediator complex and RNA polymerase II recruitment. (kim2008ccar1akey pages 1-2, mizuta2014ccar1cocoapairmediatedrecruitment pages 13-15)

2. Molecular functions, pathways, and cellular localization (evidence-weighted)

2.1 Subcellular localization

Autophagy-focused experiments indicate CALCOCO1 is predominantly cytoplasmic, with vesicle/light-membrane association and close proximity to ER structures. (stefely2020massspectrometryproteomics pages 8-11, stefely2020massspectrometryproteomics pages 11-14)

Stefely et al. also report detection of CALCOCO1 in cytoplasmic and nuclear fractions in some fractionation experiments, but their imaging and cell-line comparisons support that autophagy-relevant pools are largely cytosolic/vesicle-associated and proximal to ER. (stefely2020massspectrometryproteomics pages 17-21, stefely2020massspectrometryproteomics pages 34-41)

2.2 Core binding partners (experimentally supported)

ATG8/LC3-family proteins. Co-immunoprecipitation experiments show CALCOCO1 binds LC3/GABARAP proteins with a strong preference for MAP1LC3C, and also binds MAP1LC3B and GABARAPL2, with interactions strengthened when autophagy is blocked (e.g., chloroquine). (stefely2020massspectrometryproteomics pages 8-11, stefely2020massspectrometryproteomics pages 11-14)

Functional consequence of variant: a tumor-associated R12H variant reduced MAP1LC3C association, linking a disease-associated residue to impaired ATG8-family binding behavior. (stefely2020massspectrometryproteomics pages 11-14)

Transcriptional cofactors. In transcription contexts, CALCOCO1/CoCoA interacts functionally with p160 coactivators, and its activation domain binds CCAR1, which associates with Mediator; these interactions support Mediator recruitment to nuclear receptor transcription complexes. (kim2008ccar1akey pages 1-2)

2.3 Primary autophagy function: MTOR-regulated ER-phagy/reticulophagy

Pathway context. MTOR inhibition is a canonical autophagy-activating input. Stefely et al. show that the ATP-competitive MTOR inhibitor MLN0128 triggers a decline in CALCOCO1 abundance, while lysosomal/autophagy inhibition (chloroquine or bafilomycin A1) increases CALCOCO1 levels—supporting that CALCOCO1 is itself turned over by autophagy/lysosomes and is responsive to MTOR-regulated autophagy flux. (stefely2020massspectrometryproteomics pages 8-11)

Functional assays and effect sizes. In CRISPR sgCALCOCO1 knockout cells, ER-phagy flux measured by ER-targeted reporters was reduced:
- ~50% reduced ER-phagy signal in a GST-LSCS-GFP-cb5 assay.
- ~25% reduced ER-phagy in a Keima-cb5 assay.
These results support CALCOCO1 as a contributor (but not necessarily the sole mediator) of ER-selective autophagy under the tested conditions. (stefely2020massspectrometryproteomics pages 11-14)

Interpretation: The most evidence-supported “primary function” of CALCOCO1 in the autophagy literature is as a selective ER-phagy adaptor/receptor that couples ER-associated cargo capture to ATG8 proteins, especially via MAP1LC3C. (stefely2020massspectrometryproteomics pages 14-17, stefely2020massspectrometryproteomics pages 11-14)

2.4 Transcriptional coactivator function (mechanistic detail)

CCAR1–CoCoA–Mediator axis. Kim et al. identified CCAR1 as a CoCoA activation-domain-binding protein using GST-CoCoA pull-downs and mass spectrometry, and showed CCAR1 is needed for hormone-induced recruitment of Mediator components and RNA polymerase II to promoters and for estrogen-dependent growth of MCF-7 breast cancer cells. (kim2008ccar1akey pages 1-2)

p53 and GATA1 connections. Kim et al. also show CCAR1 and CoCoA are recruited to the p21 promoter and are required for p53-mediated transcription (qRT-PCR/ChIP contexts described in the excerpt). (kim2008ccar1akey pages 8-8) Mizuta et al. further place CoCoA in erythroid transcription, where CCAR1 and CoCoA support GATA1-dependent transcription and are co-recruited with Mediator components to the c-globin promoter during K562 differentiation; CoCoA knockdown reduced globin expression in this model. (mizuta2014ccar1cocoapairmediatedrecruitment pages 13-15)

Conceptual implication: CALCOCO1 is unusual among selective-autophagy adaptors in having substantial historical evidence as a nuclear transcriptional coactivator, suggesting that CALCOCO1 biology may be bifunctional and context-dependent (nuclear coactivation vs cytosolic selective-autophagy adaptor). (kim2008ccar1akey pages 1-2, mizuta2014ccar1cocoapairmediatedrecruitment pages 13-15)

3. Recent developments and latest research (prioritizing 2023–2024)

3.1 2024: CALCOCO1 and Golgiphagy (selective autophagy of the Golgi)

A 2024 primary study identifying YIPF3/YIPF4 as Golgiphagy receptors tested CALCOCO1 using a Golgiphagy reporter assay and siRNA knockdown in HeLa cells. In that system, CALCOCO1 knockdown alone did not decrease Golgiphagy, and even triple knockdown (YIPF3/YIPF4/CALCOCO1) retained some Golgiphagic activity, supporting redundancy and suggesting CALCOCO1 is not the dominant Golgi receptor in that specific experimental context. (kitta2024yipf3andyipf4 pages 10-11)

A 2024 expert commentary in Life Metabolism frames CALCOCO1 as a soluble ER-phagy receptor that can also act in Golgiphagy via Golgi-associated interactions (e.g., ZDHHC17), but emphasizes that CALCOCO1 and YIPF3/4 likely represent distinct Golgiphagy mechanisms rather than a single unified pathway. (ma2024jointheclub pages 3-3)

3.2 2024: Multi-omics evidence linking CALCOCO1 to Alzheimer’s disease severity

A 2024 multi-omics analysis of 87 Alzheimer’s disease patients reported 170 plasma proteins significantly altered between high vs low ADAS-Cog severity groups and listed CALCOCO1 among the top five significantly downregulated proteins in high-severity ADAS-Cog groups. (meng2024multiomicsanalysisreveals pages 2-4)

While the excerpted text does not provide CALCOCO1-specific effect sizes or p-values, the study supports the hypothesis that plasma CALCOCO1 may track with disease severity in at least one cohort and assay platform (NPX log2-scale proteomics). (meng2024multiomicsanalysisreveals pages 2-4)

3.3 2023: Cancer bioinformatics/prognostic associations (LUAD)

A 2023 lung adenocarcinoma (LUAD) study reports an association between low CALCOCO1 expression and poorer prognosis (log-rank test referenced), consistent with prior literature linking CALCOCO1/CoCoA with CCAR1-mediated p53 coactivation. Numeric hazard ratios/p-values were not present in the excerpt and therefore cannot be stated here. (wei2023npm3asa pages 12-14)

4. Current applications and real-world implementations

4.1 Translational status

Based on the retrieved sources, CALCOCO1 is not currently an established clinical target with approved CALCOCO1-directed therapeutics. Instead, CALCOCO1 appears in translational contexts mainly as:
- A candidate biomarker feature in multi-omics models of disease severity (e.g., plasma proteomics in Alzheimer’s disease). (meng2024multiomicsanalysisreveals pages 2-4)
- A cancer-related factor implicated in stem-like phenotypes in vitro (mammosphere formation) and in expression–prognosis associations in tumor datasets. (stefely2020massspectrometryproteomics pages 8-11, wei2023npm3asa pages 12-14)

4.2 Example of an experimentally demonstrated cancer-relevant phenotype

In MB231 breast cancer cells, CRISPR targeting of CALCOCO1 reduced mammosphere formation by ~50%, supporting a potential role in cancer stem-like traits (preclinical, in vitro). (stefely2020massspectrometryproteomics pages 8-11)

5. Expert opinions and authoritative synthesis

5.1 Expert synthesis on Golgiphagy receptor landscape

The 2024 Life Metabolism commentary interprets the Golgiphagy literature as involving multiple receptor systems. It positions CALCOCO1 as a receptor with a dominant ER-phagy identity and a minor Golgi-localized pool that can contribute to Golgiphagy in some settings, while the YIPF3/YIPF4 complex represents a distinct transmembrane receptor mechanism. (ma2024jointheclub pages 3-3)

5.2 Expert synthesis on coregulator selectivity in transcription

Wu et al. (2014) provide a genome-wide perspective that CALCOCO1/CoCoA acts as a selective glucocorticoid receptor (GR) coregulator, with gene-specific positive and negative effects; most affected genes were unique to each tested coregulator (including CALCOCO1), supporting pathway-selective regulation rather than global coactivation. (wu2014distinctgenomewidegenespecific pages 1-2)

6. Statistics and data highlights from recent studies (2023–2024)

• Alzheimer’s disease cohort size: 87 well-phenotyped AD patients (plasma proteomics/metabolomics); CALCOCO1 among the top five downregulated proteins in high vs low ADAS-Cog severity comparisons; 170 proteins significantly altered between high and low groups. (Publication date: Oct 2024; URL: https://doi.org/10.1186/s13195-024-01578-6). (meng2024multiomicsanalysisreveals pages 2-4)
• Golgiphagy functional assay replication: n = 4 independent experiments for Golgiphagy reporter cleavage quantification under CALCOCO1 knockdown conditions in HeLa cells (primary EMBO J study). (Publication date: May 2024; URL: https://doi.org/10.1038/s44318-024-00131-3). (kitta2024yipf3andyipf4 pages 10-11)

7. Consolidated evidence map

The table below summarizes the highest-confidence functions, interactions, and translational links for CALCOCO1 based on the retrieved evidence.

Table: This table summarizes the main experimentally supported functions, localization, interactions, and disease links of human CALCOCO1 (UniProt Q9P1Z2). It is useful as a compact evidence map spanning both its autophagy-receptor and transcriptional-coactivator roles.

8. Conclusions (evidence-weighted functional annotation)

1. Primary supported cellular role (autophagy context): CALCOCO1 functions as a soluble selective-autophagy receptor/adaptor that promotes ER-phagy/reticulophagy downstream of MTOR-regulated autophagy signaling, in part through motif-mediated binding to ATG8-family proteins, with a reported preference for MAP1LC3C. (stefely2020massspectrometryproteomics pages 14-17, stefely2020massspectrometryproteomics pages 11-14)
2. Primary supported biochemical mechanism: CALCOCO1 uses a canonical LIR (required for LC3-family binding) and a CLIR that contributes to MAP1LC3C preference; disease-associated residue changes (e.g., R12H) can reduce MAP1LC3C association. (stefely2020massspectrometryproteomics pages 11-14)
3. Distinct functional axis (nuclear transcription): CALCOCO1 (CoCoA) is also a transcriptional coactivator that cooperates with CCAR1 and Mediator to enhance transcription by nuclear receptors, p53, and GATA1; thus, CALCOCO1 biology plausibly integrates transcriptional regulation and selective autophagy in a context-dependent manner. (kim2008ccar1akey pages 1-2, mizuta2014ccar1cocoapairmediatedrecruitment pages 13-15, kim2008ccar1akey pages 8-8)
4. Recent (2023–2024) direction of the field: CALCOCO1 is increasingly discussed within a broader selective-organelle autophagy landscape, including Golgiphagy, where current data suggest cell-type- and receptor-specific redundancy, and within omics-driven biomarker discovery (e.g., plasma protein signatures of AD severity). (kitta2024yipf3andyipf4 pages 10-11, ma2024jointheclub pages 3-3, meng2024multiomicsanalysisreveals pages 2-4)

References

1. (stefely2020massspectrometryproteomics pages 8-11): Jonathan A. Stefely, Yu Zhang, Elyse C. Freiberger, Nicholas W. Kwiecien, Hala Elnakat Thomas, Alexander M. Davis, Nathaniel D. Lowry, Catherine E. Vincent, Evgenia Shishkova, Nicholas A. Clark, Mario Medvedovic, Joshua J. Coon, David J. Pagliarini, and Carol A. Mercer. Mass spectrometry proteomics reveals a function for mammalian calcoco1 in mtor-regulated selective autophagy. Feb 2020. URL: https://doi.org/10.1080/15548627.2020.1719746, doi:10.1080/15548627.2020.1719746. This article has 55 citations and is from a domain leading peer-reviewed journal.

2. (kim2008ccar1akey pages 1-2): Jeong Hoon Kim, Catherine K. Yang, Kyu Heo, Robert G. Roeder, Woojin An, and Michael R. Stallcup. Ccar1, a key regulator of mediator complex recruitment to nuclear receptor transcription complexes. Molecular cell, 31 4:510-9, Aug 2008. URL: https://doi.org/10.1016/j.molcel.2008.08.001, doi:10.1016/j.molcel.2008.08.001. This article has 169 citations and is from a highest quality peer-reviewed journal.

3. (stefely2020massspectrometryproteomics pages 14-17): Jonathan A. Stefely, Yu Zhang, Elyse C. Freiberger, Nicholas W. Kwiecien, Hala Elnakat Thomas, Alexander M. Davis, Nathaniel D. Lowry, Catherine E. Vincent, Evgenia Shishkova, Nicholas A. Clark, Mario Medvedovic, Joshua J. Coon, David J. Pagliarini, and Carol A. Mercer. Mass spectrometry proteomics reveals a function for mammalian calcoco1 in mtor-regulated selective autophagy. Feb 2020. URL: https://doi.org/10.1080/15548627.2020.1719746, doi:10.1080/15548627.2020.1719746. This article has 55 citations and is from a domain leading peer-reviewed journal.

4. (stefely2020massspectrometryproteomics pages 11-14): Jonathan A. Stefely, Yu Zhang, Elyse C. Freiberger, Nicholas W. Kwiecien, Hala Elnakat Thomas, Alexander M. Davis, Nathaniel D. Lowry, Catherine E. Vincent, Evgenia Shishkova, Nicholas A. Clark, Mario Medvedovic, Joshua J. Coon, David J. Pagliarini, and Carol A. Mercer. Mass spectrometry proteomics reveals a function for mammalian calcoco1 in mtor-regulated selective autophagy. Feb 2020. URL: https://doi.org/10.1080/15548627.2020.1719746, doi:10.1080/15548627.2020.1719746. This article has 55 citations and is from a domain leading peer-reviewed journal.

5. (mizuta2014ccar1cocoapairmediatedrecruitment pages 13-15): Shumpei Mizuta, Tomoya Minami, Haruka Fujita, Chihiro Kaminaga, Keiji Matsui, Ruri Ishino, Azusa Fujita, Kasumi Oda, Asami Kawai, Natsumi Hasegawa, Norinaga Urahama, Robert G. Roeder, and Mitsuhiro Ito. Ccar1/cocoa pair‐mediated recruitment of the mediator defines a novel pathway for gata1 function. Genes to Cells, 19:28-51, Jan 2014. URL: https://doi.org/10.1111/gtc.12104, doi:10.1111/gtc.12104. This article has 14 citations and is from a peer-reviewed journal.

6. (stefely2020massspectrometryproteomics pages 17-21): Jonathan A. Stefely, Yu Zhang, Elyse C. Freiberger, Nicholas W. Kwiecien, Hala Elnakat Thomas, Alexander M. Davis, Nathaniel D. Lowry, Catherine E. Vincent, Evgenia Shishkova, Nicholas A. Clark, Mario Medvedovic, Joshua J. Coon, David J. Pagliarini, and Carol A. Mercer. Mass spectrometry proteomics reveals a function for mammalian calcoco1 in mtor-regulated selective autophagy. Feb 2020. URL: https://doi.org/10.1080/15548627.2020.1719746, doi:10.1080/15548627.2020.1719746. This article has 55 citations and is from a domain leading peer-reviewed journal.

7. (stefely2020massspectrometryproteomics pages 34-41): Jonathan A. Stefely, Yu Zhang, Elyse C. Freiberger, Nicholas W. Kwiecien, Hala Elnakat Thomas, Alexander M. Davis, Nathaniel D. Lowry, Catherine E. Vincent, Evgenia Shishkova, Nicholas A. Clark, Mario Medvedovic, Joshua J. Coon, David J. Pagliarini, and Carol A. Mercer. Mass spectrometry proteomics reveals a function for mammalian calcoco1 in mtor-regulated selective autophagy. Feb 2020. URL: https://doi.org/10.1080/15548627.2020.1719746, doi:10.1080/15548627.2020.1719746. This article has 55 citations and is from a domain leading peer-reviewed journal.

8. (kim2008ccar1akey pages 8-8): Jeong Hoon Kim, Catherine K. Yang, Kyu Heo, Robert G. Roeder, Woojin An, and Michael R. Stallcup. Ccar1, a key regulator of mediator complex recruitment to nuclear receptor transcription complexes. Molecular cell, 31 4:510-9, Aug 2008. URL: https://doi.org/10.1016/j.molcel.2008.08.001, doi:10.1016/j.molcel.2008.08.001. This article has 169 citations and is from a highest quality peer-reviewed journal.

9. (kitta2024yipf3andyipf4 pages 10-11): Shinri Kitta, Tatsuya Kaminishi, Momoko Higashi, Takayuki Shima, Kohei Nishino, Nobuhiro Nakamura, Hidetaka Kosako, Tamotsu Yoshimori, and Akiko Kuma. Yipf3 and yipf4 regulate autophagic turnover of the golgi apparatus. The EMBO Journal, 43:2954-2978, May 2024. URL: https://doi.org/10.1038/s44318-024-00131-3, doi:10.1038/s44318-024-00131-3. This article has 16 citations.

10. (ma2024jointheclub pages 3-3): Xiaoli Ma and Hong Zhang. Join the club: yipf3 and yipf4 act as golgiphagy receptors. Life Metabolism, Dec 2024. URL: https://doi.org/10.1093/lifemeta/load049, doi:10.1093/lifemeta/load049. This article has 1 citations.

11. (meng2024multiomicsanalysisreveals pages 2-4): Lingqi Meng, Han Jin, Burak Yulug, Ozlem Altay, Xiangyu Li, Lutfu Hanoglu, Seyda Cankaya, Ebru Coskun, Ezgi Idil, Rahim Nogaylar, Ahmet Ozsimsek, Saeed Shoaie, Hasan Turkez, Jens Nielsen, Cheng Zhang, Jan Borén, Mathias Uhlén, and Adil Mardinoglu. Multi-omics analysis reveals the key factors involved in the severity of the alzheimer’s disease. Alzheimer's Research & Therapy, Oct 2024. URL: https://doi.org/10.1186/s13195-024-01578-6, doi:10.1186/s13195-024-01578-6. This article has 42 citations and is from a domain leading peer-reviewed journal.

12. (wei2023npm3asa pages 12-14): Shanshan Wei, Jing Xing, Kaining Lu, Kai Wang, and Wanjun Yu. Npm3 as a novel oncogenic factor and poor prognostic marker contributes to cell proliferation and migration in lung adenocarcinoma. Hereditas, May 2023. URL: https://doi.org/10.1186/s41065-023-00289-6, doi:10.1186/s41065-023-00289-6. This article has 6 citations and is from a peer-reviewed journal.

13. (wu2014distinctgenomewidegenespecific pages 1-2): Dai-Ying Wu, Chen-Yin Ou, Rajas Chodankar, Kimberly D. Siegmund, and Michael R. Stallcup. Distinct, genome-wide, gene-specific selectivity patterns of four glucocorticoid receptor coregulators. Nuclear Receptor Signaling, Jan 2014. URL: https://doi.org/10.1621/nrs.12002, doi:10.1621/nrs.12002. This article has 42 citations and is from a peer-reviewed journal.

14. (mizuta2014ccar1cocoapairmediatedrecruitment pages 11-12): Shumpei Mizuta, Tomoya Minami, Haruka Fujita, Chihiro Kaminaga, Keiji Matsui, Ruri Ishino, Azusa Fujita, Kasumi Oda, Asami Kawai, Natsumi Hasegawa, Norinaga Urahama, Robert G. Roeder, and Mitsuhiro Ito. Ccar1/cocoa pair‐mediated recruitment of the mediator defines a novel pathway for gata1 function. Genes to Cells, 19:28-51, Jan 2014. URL: https://doi.org/10.1111/gtc.12104, doi:10.1111/gtc.12104. This article has 14 citations and is from a peer-reviewed journal.

15. (mizuta2014ccar1cocoapairmediatedrecruitment pages 12-13): Shumpei Mizuta, Tomoya Minami, Haruka Fujita, Chihiro Kaminaga, Keiji Matsui, Ruri Ishino, Azusa Fujita, Kasumi Oda, Asami Kawai, Natsumi Hasegawa, Norinaga Urahama, Robert G. Roeder, and Mitsuhiro Ito. Ccar1/cocoa pair‐mediated recruitment of the mediator defines a novel pathway for gata1 function. Genes to Cells, 19:28-51, Jan 2014. URL: https://doi.org/10.1111/gtc.12104, doi:10.1111/gtc.12104. This article has 14 citations and is from a peer-reviewed journal.

16. (mizuta2014ccar1cocoapairmediatedrecruitment pages 1-2): Shumpei Mizuta, Tomoya Minami, Haruka Fujita, Chihiro Kaminaga, Keiji Matsui, Ruri Ishino, Azusa Fujita, Kasumi Oda, Asami Kawai, Natsumi Hasegawa, Norinaga Urahama, Robert G. Roeder, and Mitsuhiro Ito. Ccar1/cocoa pair‐mediated recruitment of the mediator defines a novel pathway for gata1 function. Genes to Cells, 19:28-51, Jan 2014. URL: https://doi.org/10.1111/gtc.12104, doi:10.1111/gtc.12104. This article has 14 citations and is from a peer-reviewed journal.

17. (mizuta2014ccar1cocoapairmediatedrecruitment pages 7-8): Shumpei Mizuta, Tomoya Minami, Haruka Fujita, Chihiro Kaminaga, Keiji Matsui, Ruri Ishino, Azusa Fujita, Kasumi Oda, Asami Kawai, Natsumi Hasegawa, Norinaga Urahama, Robert G. Roeder, and Mitsuhiro Ito. Ccar1/cocoa pair‐mediated recruitment of the mediator defines a novel pathway for gata1 function. Genes to Cells, 19:28-51, Jan 2014. URL: https://doi.org/10.1111/gtc.12104, doi:10.1111/gtc.12104. This article has 14 citations and is from a peer-reviewed journal.

18. (stefely2020massspectrometryproteomics pages 5-8): Jonathan A. Stefely, Yu Zhang, Elyse C. Freiberger, Nicholas W. Kwiecien, Hala Elnakat Thomas, Alexander M. Davis, Nathaniel D. Lowry, Catherine E. Vincent, Evgenia Shishkova, Nicholas A. Clark, Mario Medvedovic, Joshua J. Coon, David J. Pagliarini, and Carol A. Mercer. Mass spectrometry proteomics reveals a function for mammalian calcoco1 in mtor-regulated selective autophagy. Feb 2020. URL: https://doi.org/10.1080/15548627.2020.1719746, doi:10.1080/15548627.2020.1719746. This article has 55 citations and is from a domain leading peer-reviewed journal.

Artifacts

• Edison artifact artifact-00

Citations

1. stefely2020massspectrometryproteomics pages 11-14
2. stefely2020massspectrometryproteomics pages 8-11
3. ma2024jointheclub pages 3-3
4. meng2024multiomicsanalysisreveals pages 2-4
5. wu2014distinctgenomewidegenespecific pages 1-2
6. stefely2020massspectrometryproteomics pages 14-17
7. stefely2020massspectrometryproteomics pages 17-21
8. stefely2020massspectrometryproteomics pages 34-41
9. stefely2020massspectrometryproteomics pages 5-8
10. https://doi.org/10.1186/s13195-024-01578-6
11. https://doi.org/10.1038/s44318-024-00131-3
12. https://doi.org/10.1080/15548627.2020.1719746;
13. https://doi.org/10.1073/pnas.2315550121
14. https://doi.org/10.1093/lifemeta/load049
15. https://doi.org/10.1016/j.molcel.2008.08.001;
16. https://doi.org/10.1111/gtc.12104;
17. https://doi.org/10.1621/nrs.12002
18. https://doi.org/10.1080/15548627.2024.2353502;
19. https://doi.org/10.1038/s41556-024-01356-4
20. https://doi.org/10.1038/s44318-024-00131-3;
21. https://doi.org/10.1186/s13195-024-01578-6;
22. https://doi.org/10.1186/s41065-023-00289-6
23. https://doi.org/10.1080/15548627.2020.1719746
24. https://doi.org/10.1080/15548627.2020.1719746,
25. https://doi.org/10.1016/j.molcel.2008.08.001,
26. https://doi.org/10.1111/gtc.12104,
27. https://doi.org/10.1038/s44318-024-00131-3,
28. https://doi.org/10.1093/lifemeta/load049,
29. https://doi.org/10.1186/s13195-024-01578-6,
30. https://doi.org/10.1186/s41065-023-00289-6,
31. https://doi.org/10.1621/nrs.12002,